United Neuroscience Ltd.
๐ฎ๐ชIreland
- Country
- ๐ฎ๐ชIreland
- Ownership
- Subsidiary
- Established
- 2014-01-01
- Employees
- 11
- Market Cap
- -
Study of UB-312 in Healthy Participants and Parkinson's Disease Patients
Phase 1
Completed
- Conditions
- ParkinsonismParkinson's Disease
- Interventions
- Biological: UB-312Biological: Placebo
- First Posted Date
- 2019-08-30
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- United Neuroscience Ltd.
- Target Recruit Count
- 70
- Registration Number
- NCT04075318
- Locations
- ๐ณ๐ฑ
Centre for Human Drug Research, Leiden, Netherlands
An Extension Study of V203-AD Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UB-311
Phase 2
Terminated
- Conditions
- Alzheimer's Disease
- Interventions
- Biological: UB-311Drug: Placebo
- First Posted Date
- 2018-05-22
- Last Posted Date
- 2021-01-26
- Lead Sponsor
- United Neuroscience Ltd.
- Target Recruit Count
- 34
- Registration Number
- NCT03531710
- Locations
- ๐จ๐ณ
National Taiwan University Hospital (NTUH), Taipei, Taiwan
๐จ๐ณLinkou Chang Gung Memorial Hospital (LK-CGMH), Taoyuan, Taiwan
๐จ๐ณKaohsiung Chang Gung Memorial Hospital (KS-CGMH), Kaohsiung, Taiwan
Evaluate the Safety, Tolerability, Immunogenicity and Efficacy of UB-311 in Mild Alzheimer's Disease (AD) Patients
Phase 2
Completed
- Conditions
- Alzheimer's Disease
- Interventions
- Biological: UB-311Drug: Placebo
- First Posted Date
- 2015-09-16
- Last Posted Date
- 2020-03-17
- Lead Sponsor
- United Neuroscience Ltd.
- Target Recruit Count
- 43
- Registration Number
- NCT02551809
- Locations
- ๐จ๐ณ
National Taiwan University Hospital (NTUH), Taipei, Taiwan
๐จ๐ณTaipei Veterans General Hospital (TVGH), Taipei, Taiwan
๐จ๐ณLinkou Chang Gung Memorial Hospital (LK-CGMH), Taoyuan, Taiwan
ยฉ Copyright 2025. All Rights Reserved by MedPath